Are you Dr. Mehregan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1314 N Macomb St
Monroe, MI 48162Phone+1 734-242-6872Fax+1 734-242-4962
Summary
- Dr. David Mehregan, MD is a board certified dermatologist in Monroe, Michigan. He is currently licensed to practice medicine in Michigan, Missouri, and Wisconsin. He is affiliated with ProMedica Monroe Regional Hospital.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 1990 - 1991- Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 1987 - 1990
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1986 - 1987
Wayne State University School of MedicineClass of 1986
Certifications & Licensure
UT State Medical License 2005 - 2026
OH State Medical License 1991 - 2021
AZ State Medical License 2011 - 2020
IA State Medical License 2011 - 2020
ID State Medical License 2011 - 2020
IL State Medical License 2011 - 2020
WA State Medical License 2011 - 2020- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
- Join now to see all
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 4 citationsInterstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis.Taryn Huizenga, Jessica Kado, Brenda L Pellicane, Judy H. Borovicka, Darius R. Mehregan
Cutis. 2018-05-01 - Itchy bumps with new-onset bullae.Syed Hamzah Mahmood, Anthony Van Vreede, David A. Mehregan
Pediatric Dermatology. 2018-01-01 - 2 citationsSacral zoster with a primary complaint of difficulty voidingJeremy A. Grekin, David A. Mehregan
JAAD Case Reports. 2017-11-01
Press Mentions
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific MeetingApril 12th, 2018
Professional Memberships
- Fellow
